Endo starts manufacturing Novavax’s potential COVID-19 vaccine
- The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the UK
- Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product